Target intelligence / Profile preview

RNA, U4 small nuclear 32, pseudogene (RNU4-32P)

Target
RNU4-32P
Molecular classification
Other (pseudogene, non-coding RNA)
01

Overview

**RNU4-32P** is a pseudogene related to the U4 small nuclear RNA gene family. Pseudogenes are genomic DNA sequences similar to normal genes but are typically non-functional because they lack regulatory elements or contain disabling mutations. RNU4-32P does not code for a functional RNA or protein and is not involved in any known molecular pathways, biological functions, or diseases. It is one of multiple dispersed U4 snRNA pseudogenes in the human genome[1][3][4]. **Key notes:** - RNU4-32P is a *pseudogene* and not a functional gene. - It is not a therapeutic target, receptor, enzyme, transporter, or any molecule commonly targeted by drugs. - There is no evidence for any role in disease, biological function, drug targeting, or use as a biomarker[1][4]. - 'U4' in its name refers to its sequence homology with the U4 small nuclear RNA (snRNA), which is involved in splicing as part of the major spliceosome; however, the pseudogene variant does not contribute to this activity[3][4]. **On Is_incorrect:** - The entry "RNU4-32P" is not a drug or therapeutic target—it is a pseudogene, not an active molecule or receptor. Thus, for therapeutic/drug discovery contexts, inputting this as a 'target' is not correct and may indicate a mistaken search or input[1][4].

Other names
RNU4-32PU4 small nuclear RNA pseudogene 32RNA, U4 Small Nuclear 32, Pseudogene

Beyond the preview

Go deeper on RNA, U4 small nuclear 32, pseudogene (RNU4-32P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U4 small nuclear 32, pseudogene (RNU4-32P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call